"SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond." by Katherine Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Follow Contact

Article

SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond.

Lancet Diabetes Endocrinol

Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, WA 99204, USA

Link

Document Type

Article

Publication Date

1-1-2021

Keywords

Benzhydryl Compounds,
Cardiovascular Diseases,
Diabetes Mellitus,
Glucosides,
Humans,
Kidney,
Renal Insufficiency, Chronic,
Sodium-Glucose Transporter 2

Disciplines

Endocrinology, Diabetes, and Metabolism

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Citation Information

Katherine Tuttle. "SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond." Lancet Diabetes Endocrinol (2021)
Available at: http://works.bepress.com/katherine-tuttle/356/